Founded in 2000, Genomic Health is a life science company that conducts genomic research to develop clinically validated molecular diagnostics, which provide individualized information on the likelihood of disease recurrence and response to certain types of therapy. These diagnostic technologies generate information that is used by physicians and patients in making treatment decisions. The company s first test, the Oncotype DX, was launched in 2004. The test provides physicians and patients with a quantitative assessment of the likelihood of breast cancer recurrence in individuals, as well as the chemotherapy benefit in early-stage breast cancer patients. Genomic Health is headquartered in Redwood City, Calif.